Acta Dermato-Venereologica (May 2022)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis

  • Andreas Wollenberg,
  • Danielle Marcoux,
  • Jonathan I. Silverberg,
  • Valeria Aoki,
  • Eulalia Baselga,
  • Haixin Zhang,
  • Noah A. Levit,
  • Alain Taieb,
  • Ana B. Rossi

DOI
https://doi.org/10.2340/actadv.v102.854
Journal volume & issue
Vol. 102

Abstract

Read online

This post hoc analysis examined SCORing Atopic Dermatitis (SCORAD) outcomes in 471 paediatric patients (children age 6– 86%) patients achieved mild or absent pruritus and sleep loss at week 52. In conclusion, dupilumab ± topical corticosteroids resulted in rapid and significant improvements in all aspects of SCORAD analysed, and the results were sustained over 1 year.

Keywords